COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain.
Journal
Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
25
04
2023
received:
20
12
2022
accepted:
28
04
2023
medline:
5
9
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
ppublish
Résumé
Peroxisome injury occurs in the central nervous system (CNS) during multiple virus infections that result in neurological disabilities. We investigated host neuroimmune responses and peroxisome biogenesis factors during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using a multiplatform strategy. Brain tissues from coronavirus disease 2019 (COVID-19) (n = 12) and other disease control (ODC) (n = 12) patients, as well as primary human neural cells and Syrian hamsters, infected with a clinical variant of SARS-CoV-2, were investigated by droplet digital polymerase chain reaction (ddPCR), quantitative reverse transcriptase PCR (RT-qPCR), and immunodetection methods. SARS-CoV-2 RNA was detected in the CNS of 4 patients with COVID-19 with viral protein (NSP3 and spike) immunodetection in the brainstem. Olfactory bulb, brainstem, and cerebrum from patients with COVID-19 showed induction of pro-inflammatory transcripts (IL8, IL18, CXCL10, NOD2) and cytokines (GM-CSF and IL-18) compared to CNS tissues from ODC patients (p < 0.05). Peroxisome biogenesis factor transcripts (PEX3, PEX5L, PEX11β, and PEX14) and proteins (PEX3, PEX14, PMP70) were suppressed in the CNS of COVID-19 compared to ODC patients (p < 0.05). SARS-CoV-2 infection of hamsters revealed viral RNA detection in the olfactory bulb at days 4 and 7 post-infection while inflammatory gene expression was upregulated in the cerebrum of infected animals by day 14 post-infection (p < 0.05). Pex3 transcript levels together with catalase and PMP70 immunoreactivity were suppressed in the cerebrum of SARS-CoV-2 infected animals (p < 0.05). COVID-19 induced sustained neuroinflammatory responses with peroxisome biogenesis factor suppression despite limited brainstem SARS-CoV-2 neurotropism in humans. These observations offer insights into developing biomarkers and therapies, while also implicating persistent peroxisome dysfunction as a contributor to the neurological post-acute sequelae of COVID-19. ANN NEUROL 2023;94:531-546.
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
531-546Subventions
Organisme : CIHR
ID : A5555
Pays : Canada
Informations de copyright
© 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain 2021;144:3576-3588.
Nath A. Neurologic manifestations of severe acute respiratory syndrome coronavirus 2 infection. Continuum (Minneap Minn) 2021;27:1051-1065.
Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management. BMJ 2021;26:n1648.
Lee M-H, Perl DP, Nair G, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med 2020;384:481-483.
Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020;19:919-929.
Colombo D, Falasca L, Marchioni L, et al. Neuropathology and inflammatory cell characterization in 10 autoptic COVID-19 brains. Cells 2021;10:2262.
Khan M, Yoo SJ, Clijsters M, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 2021;184:5932-49.e15.
Yang AC, Kern F, Losada PM, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 2021;595:565-571.
Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021;24:168-175.
Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 2022;14:1-6.
Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 2020;370:856-860.
Chen R, Wang K, Yu J, et al. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 2020;11:573095.
Davies J, Randeva HS, Chatha K, et al. Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep 2020;22:4221-4226.
Clough E, Inigo J, Chandra D, et al. Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID. J Neuroimmune Pharmacol 2021;2:1-15.
Almutairi MM, Sivandzade F, Albekairi TH, et al. Neuroinflammation and its impact on the pathogenesis of COVID-19. Front Med (Lausanne) 2021;8:745789.
Rutkai I, Mayer MG, Hellmers LM, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun 2022;13:1745.
Dunn N, Mullee M, Perry VH, Holmes C. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord 2005;19:91-94.
Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013;369:1306-1316.
Kao LT, Sheu JJ, Lin HC, et al. Association between sepsis and dementia. J Clin Neurosci 2015;22:1430-1433.
Girard TD, Thompson JL, Pandharipande PP, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. Lancet Respir Med 2018;6:213-222.
Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov 2021;7:43.
Rodrigues TS, de Sá KSG, Ishimoto AY, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 2021;218:e20201707.
Berger J, Dorninger F, Forss-Petter S, Kunze M. Peroxisomes in brain development and function. Biochim Biophys Acta 2016;1863:934-955.
Kassmann CM. Myelin peroxisomes - essential organelles for the maintenance of white matter in the nervous system. Biochimie 2014;98:111-118.
Uzor NE, McCullough LD, Tsvetkov AS. Peroxisomal dysfunction in neurological diseases and brain aging. Front Cell Neurosci 2020;14:44.
Bender S, Reuter A, Eberle F, et al. Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus. PLoS Pathog 2015;11:e1005264.
Di Cara F, Andreoletti P, Trompier D, et al. Peroxisomes in immune response and inflammation. Int J Mol Sci 2019;20:3877.
Wong CP, Xu Z, Hou S, et al. Interplay between zika virus and peroxisomes during infection. Cells 2019;8:725.
Santos MJ, Quintanilla RA, Toro A, et al. Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem 2005;280:41057-41068.
Gray E, Rice C, Hares K, et al. Reductions in neuronal peroxisomes in multiple sclerosis grey matter. Mult Scler 2014;20:651-659.
Roczkowsky A, Doan MAL, Hlavay B, et al. Peroxisome injury in multiple sclerosis: protective effects of 4-phenylbutyrate in CNS-associated macrophages. J Neurosci 2022;42(37):7152-7165.
Xu Z, Asahchop EL, Branton WG, et al. MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: implications for virus biology, disease mechanisms and neuropathology. PLoS Pathog 2017;13:e1006360.
Doan MAL, Roczkowsky A, Smith M, et al. Infection of glia by human Pegivirus suppresses peroxisomal and antiviral signaling pathways. J Virol 2021;95:e0107421.
Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020;583:459-468.
Knoblach B, Ishida R, Hobman TC, Rachubinski RA. Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells. Mol Biol Cell 2021;32:1273-1282.
McKenzie BA, Mamik MK, Saito LB, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A 2018;115:E6065-e74.
Branton WG, Fernandes JP, Mohammadzadeh N, et al. Microbial molecule ingress promotes neuroinflammation and brain CCR5 expression in persons with HIV-associated neurocognitive disorders. Brain Behav Immun 2022;3:110-123.
Mamik MK, Asahchop EL, Chan WF, et al. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration. J Neurosci 2016;36:10683-10695.
Mamik MK, Hui E, Branton WG, et al. HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation. J Neuroimmune Pharmacol 2017;12:233-248.
Limonta D, Branton W, Wong CP, et al. Use of primary human fetal astrocytes and tissue explants as ex vivo models to study zika virus infection of the developing brain. Methods Mol Biol 2020;2142:251-259.
Walsh JG, Reinke SN, Mamik MK, et al. Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology 2014;13:35.
McKenzie BA, Fernandes JP, Doan MAL, et al. Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis. J Neuroinflammation 2020;17:253.
Limonta D, Dyna-Dagman L, Branton W, et al. Nodosome inhibition as a novel broad-Spectrum antiviral strategy against arboviruses, enteroviruses, and SARS-CoV-2. Antimicrob Agents Chemother 2021;65:e0049121.
Lin YC, Malott RJ, Ward L, et al. Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples. Sci Rep 2022;12:5418.
Mohammadzadeh N, Roda W, Branton WG, et al. Lentiviral infections persist in brain despite effective antiretroviral therapy and neuroimmune activation. MBio 2021;12(6):e0278421.
Boghozian R, McKenzie BA, Saito LB, et al. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: implications for regulation of neuroinflammation. Glia 2017;65:1590-1606.
Lee JS, Goldstein JM, Moon JL, et al. Analysis of the initial lot of the CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. PLOS ONE 2021;16:e0260487.
Wong CP, Xu Z, Power C, Hobman TC. Targeted elimination of peroxisomes during viral infection: lessons from HIV and other viruses. DNA Cell Biol 2018;37:417-421.
Imai M, Iwatsuki-Horimoto K, Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci 2020;117:16587-16595.
Ghaedi K, Tamura S, Okumoto K, et al. The peroxin pex3p initiates membrane assembly in peroxisome biogenesis. Mol Biol Cell 2000;11:2085-2102.
Lee MH, Perl DP, Steiner J, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain 2022;145:2555-2568.
de Melo GD, Lazarini F, Levallois S, et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med 2021;13(596):eabf8396.
Käufer C, Schreiber CS, Hartke A-S, et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine 2022;79:79.
Kishimoto-Urata M, Urata S, Kagoya R, et al. Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit. Sci Rep 2022;12:5728.
Crunfli F, Carregari VC, Veras FP, et al. Morphological, cellular and molecular basis of brain infection in COVID-19 patients. PNAS 2022;119(35):e2200960119.
Andrews MG, Mukhtar T, Eze UC, et al. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc Natl Acad Sci U S A 2022;119:e2122236119.
Tremblay M-E, Madore C, Bordeleau M, et al. Neuropathobiology of COVID-19: the role for glia. Front Cell Neurosci 2020;14:592214.
Tavčar P, Potokar M, Kolenc M, et al. Neurotropic viruses, astrocytes, and COVID-19. Front Cell Neurosci 2021;15:662578.
Pekny M, Pekna M, Messing A, et al. Astrocytes: a central element in neurological diseases. Acta Neuropathol 2016;131:323-345.
Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci 2012;32:6391-6410.
Lian H, Litvinchuk A, Chiang AC, et al. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer's disease. J Neurosci 2016;36:577-589.
Toldo S, Bussani R, Nuzzi V, et al. Inflammasome formation in the lungs of patients with fatal COVID-19. Inflamm Res 2021;70:7-10.
Junqueira C, Crespo Â, Ranjbar S, et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 2022;606:576-584.
Vijay R, Fehr AR, Janowski AM, et al. Virus-induced inflammasome activation is suppressed by prostaglandin D(2)/DP1 signaling. Proc Natl Acad Sci U S A 2017;114:E5444-e53.
Yang CP, Chang CM, Yang CC, et al. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun 2022;103:19-27.
Farré JC, Mahalingam SS, Proietto M, Subramani S. Peroxisome biogenesis, membrane contact sites, and quality control. EMBO Rep 2019;20:e46864.
Jean Beltran PM, Cook KC, Hashimoto Y, et al. Infection-induced peroxisome biogenesis is a metabolic strategy for herpesvirus replication. Cell Host Microbe 2018;24:526-41.e7.